EXACT Therapeutics

Oslo, Norway

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

$13.1M raised

Dec 2024

Post-IPO Equity

Biotechnology Therapeutics

Top Investors

Investinor BaseN Sundt AS Helene Sundt Anders Wold

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EXACT Therapeutics

How much funding has EXACT Therapeutics raised?

EXACT Therapeutics has raised $13.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.

Who are EXACT Therapeutics's investors?

EXACT Therapeutics's investors include Investinor, BaseN, Sundt AS, Helene Sundt, Anders Wold.

Where is EXACT Therapeutics headquartered?

EXACT Therapeutics is headquartered in Oslo, Norway.

What does EXACT Therapeutics do?

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

What stage is EXACT Therapeutics at?

EXACT Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 3, 2024.

MLA

"EXACT Therapeutics — Funding & Investors." VCBacked, December 3, 2024, https://www.vcbacked.co/company/exact-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). EXACT Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exact-therapeutics

Wikipedia (cite web)

{{cite web |title=EXACT Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exact-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 3, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K